Showing results (161-170 of 392) with videos related to
Sort By:
Pageof 40
European Journal of Haematology|August 1, 2024
Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma-A retrospective multicenter cohort studyZelal Guel Dilbaz, Sophy Denker, Carla Ankermann, et al.Blood|July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSGAndrea Schnaiter, Peter Paschka, Marianna Rossi, et al.Leukemia|May 12, 2018
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN studyStephan Stilgenbauer, Veronique Leblond, Robin Foà, et al.Cellular & Molecular Biology Letters|July 3, 2024
Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasionJunnan Liu, Xue Wang, Wencheng Jiang, et al.Blood|July 5, 2003
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcomeDirk Kienle, Alexander Kröber, Tiemo Katzenberger, et al.Leukemia & Lymphoma|October 25, 2017
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcomeDaniela Steinbrecher, Billy Michael Chelliah Jebaraj, Christof Schneider, et al.Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.Cell Death & Disease|July 3, 2024
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylationStefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, et al.Leukemia|August 29, 2019
Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN studyFrancesc Bosch, Guy Cantin, Agostino Cortelezzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow TransplantationKate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.Pageof 40